<DOC>
	<DOCNO>NCT02092805</DOCNO>
	<brief_summary>The purpose study assess efficacy rTMS primary motor cortex patient suffer malignant visceral pain . Thirty four patient include study . They divide randomly 2 group use close envelop real rTMS group sham group . Real rTMS hand area motor cortex ( 20 Hz , 10 train inter train interval 30 second total pulse 2000 , intensity 80 % motor threshold ) every day ten consecutive day ( 5 days/week ) coil elevate angle away head sham stimulation . Patients evaluate verbal descriptor scale ( VDS ) , visual analog scale ( VAS ) , Hamilton rating scale depression ( HAM-D ) baseline , 1st , 5th , 10th session , 15 day 1 month end session . Serum human dynorphin ( Dyn ) level measure baseline , 5th 10th session .</brief_summary>
	<brief_title>rTMS Treatment Visceral Pain Secondary Malignancy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Visceral Pain</mesh_term>
	<criteria>All patient within age group 1865 year malignant visceral pain resistant medical treatment least 2 month associate significant adverse effect medication involve study . We exclude patient intracranial metallic device pacemaker device . We also exclude extensive myocardial ischemia , unstable angina know epilepsy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>VAS</keyword>
	<keyword>VDS</keyword>
	<keyword>HAM-D</keyword>
	<keyword>Visceral pain</keyword>
	<keyword>Malignancy</keyword>
	<keyword>rTMS</keyword>
	<keyword>Motor cortex</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Dynorphin</keyword>
</DOC>